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Abstract
Francisella tularensis is a highly infectious bacterium causing the zoonotic disease tularaemia. During its infectious cycle, F.
tularensis is not only exposed to the intracellular environment of macrophages but also resides transiently in extracellular
compartments, in particular during its systemic dissemination. The screening of a bank of F. tularensis LVS transposon
insertion mutants on chemically defined medium (CDM) led us to identify a gene, designated trkH, encoding a homolog of
the potassium uptake permease TrkH. Inactivation of trkH impaired bacterial growth in CDM. Normal growth of the mutant
was only restored when CDM was supplemented with potassium at high concentration. Strikingly, although not required for
intracellular survival in cell culture models, TrkH appeared to be essential for bacterial virulence in the mouse. In vivo
kinetics of bacterial dissemination revealed a severe defect of multiplication of the trkH mutant in the blood of infected
animals. The trkH mutant also showed impaired growth in blood ex vivo. Genome sequence analyses suggest that the Trk
system constitutes the unique functional active potassium transporter in both tularensis and holarctica subspecies. Hence,
the impaired survival of the trkH mutant in vivo is likely to be due to its inability to survive in the low potassium
environment (1–5 mM range) of the blood. This work unravels thus the importance of potassium acquisition in the
extracellular phase of the F. tularensis infectious cycle. More generally, potassium could constitute an important mineral
nutrient involved in other diseases linked to systemic dissemination of bacterial pathogens.
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Introduction
Francisella tularensis is a Gram-negative bacterium responsible for
the disease tularemia in a large number of mammalian species.
Four different subspecies (subsp.) of F. tularensis that differ in
virulence and geographic distribution have been characterized and
are designated subsp. tularensis (type A), holarctica (type B), novicida
and mediasiatica. F. tularensis subsp. tularensis is the most virulent
subspecies causing a severe disease in humans, whereas F. tularensis
subsp. holarctica causes a similar disease but of less severity [1].
Because of its high infectivity and lethality, F. tularensis is
considered a potential bioterrorism agent [2].
F. tularensis is a facultative intracellular bacterium that infects
and replicates mainly inside macrophages [3]. The molecular
mechanisms by which Francisella adapts to life inside host cells has
just begun to be elucidated. Many novel genes necessary for
Francisella pathogenicity have been discovered in the past few years
[4]. These include notably genes located in the Francisella
pathogenicity island (FPI) [5,6,7,8,9,10,11,12], and genes encod-
ing the regulatory proteins MglA, SspA, FevR, PmrA and MigR,
which regulate expression of the FPI [5,13,14,15,16,17]; see [18]
for a recent review. In addition, several recent genome-scale
random and site-directed mutagenesis studies have led to the
identification of novel genes important for replication inside
macrophages and/or survival in mice [7,19,20,21,22,23,24].
However, the molecular mechanisms underlying the contribution
of the identified genes to virulence have been addressed for only a
limited number of them.
Remarkably, during its infectious cycle, F. tularensis is not only
exposed to the intracellular environment of macrophages, but also
to extracellular compartments [25], in particular to blood during
its systemic dissemination [26,27]. F. tularensis survival and
multiplication in an infected host requires, in addition to the
development of sophisticated strategies to subvert the host immune
defences [28,29], the capacity to acquire enough essential nutrients
in each of the infected niches. We have recently shown that F.
tularensis was able to use the available pool of intracellular
gluthatione as a source of cysteine to multiply efficiently in
eukaryotic host cells [24]. Since the availability of organic or
mineral sources can vary considerably between the intracellular
and the extracellular milieu, adaptation to these variations is
crucial for F. tularensis. In this respect, several studies have already
highlighted the importance of amino acid and nucleotide
biosynthesis and uptake for the survival of pathogenic bacteria
in blood (see for example [30] and references therein). However,
bacterial adaptation to the peculiar ionic conditions encountered
in blood has been largely understudied so far.
In the present study, the screening of a bank of LVS transposon
insertion mutants on chemically defined medium led us to identify
a mutant in a gene encoding the predicted potassium permease
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TrkH in potassium acquisition, normal growth of the trkH mutant
in broth could only be restored by adding high potassium
concentration. Strikingly, although not required for intracellular
survival of LVS in cell culture models, TrkH appeared to play a
major role in persistence and multiplication in the blood of
infected mice.
Results
Phenotypic Screen for Auxotrophic Mutants
Our initial aim was to identify novel nutritional requirements of
F. tularensis. Therefore, we used a simple screening procedure [31]
to isolate putative auxotrophic mutants of F. tularensis LVS. Briefly,
banks of Km
R colonies, generated by HimarFT transposon
mutagenesis, were screened for growth on chemically defined
medium (CDM). From approximately 2,500 clones, eight isolates
failed to grow on CDM (i.e. 0.3%). This percentage is in agreement
with the generally obtained values for that type of screens. The
transposon insertion sites of the selected mutants were then
determined (Table 1). Two mutants corresponded to a transposon
insertion in genes of the purine biosynthetic pathway: one, in gene
FTL_1860 (or purL, encoding a phosphoribosyl formylglycinami-
dine synthase); and the other, in the adjacent gene FTL_1861 (or
purF, encoding an amidophosphoribosyl transferase). One mutant
(FTL_0028) had an insertion upstream of a pyrimidine biosyn-
thetic gene (132 bp upstream of pyrB, encoding an aspartate
carbamoyltransferase). Two mutants in the aromatic amino acid
biosynthetic pathway were identified; one in the gene FTL_1966
(trpE, encoding an anthranilate synthase component I), and the
other in FTL_0173, (aroE, a Shikimate 5-dehydrogenase). In
addition to these auxotrophic mutants, one mutant had an
insertion in gene FTL_1962 encoding a hypothetical 113 amino
acid long protein and one mutant had an insertion immediately
upstream (11 bp) of gene FTL_0699, an ortholog of rluD of E. coli
encoding the ribosomal large subunit pseudouridine synthase D.
In E. coli, although the rluD gene is dispensable for growth, a rluD
knock-out mutant is extremely slow-growing, suggesting that the
FTL_0699 mutant of LVS was selected on CDM because of a
growth defect. Finally, two mutants corresponded to two distinct
transposon insertions in gene FTL_1708 (the first mutant carried
an insertion 216 bp and the second one, 816 bp, after the start
codon of trkH). The gene FTL_1708 encodes a protein of 484
amino acids, homologous to the TrkH potassium transporters of
Salmonella typhimurium and E. coli K12 (43% and amino acid identity
and 65% amino acid similarity), and was hence designated trkH.
Southern blot analysis confirmed the presence of a single
transposon insertion in all the strains tested (Figure S1).
Since the trkH gene had never been identified in previous
screens, we hereafter decided to focus on the trkH mutant, and to
evaluate the importance of potassium acquisition in F. tularensis
physiopathology.
In Silico Analysis
The bacterial Trk potassium transport system consists of a
membrane-spanning protein (TrkH), constituting the translocating
subunit, and a peripheral membrane-associated nucleotide
binding protein (TrkA), required to energize the system [32].
The genes encoding these two components are present and highly
conserved in the genomes of the four F. tularensis subsps. The TrkH
protein of F. tularensis LVS (encoded by FTL_1708) consists of 484
amino acids and is predicted to be a membrane protein with ten
transmembrane helices (using the TMHMM prediction program).
FTL_1708 shares 100% and 99.8% amino acid identity with
TrkH of F. tularensis subsp. holarctica (OSU18 strain, FTH_1645),
and F. tularensis subsp. tularensis (Schu S4 strain, FTT1638),
respectively. The gene FTL_1708 is flanked by two genes that are
encoded on the opposite DNA strand, indicating that FTL_1708 is
transcribed as a monocistronic unit (Figure 1A, B). No paralog of
trkH was identified in the LVS genome.
The trkA gene is not located in the same locus as trkH in the LVS
chromosome, unlike in the Vibrio vulnificus genome [33] where the
two genes are contiguous and constitute an operon. The LVS trkA
gene (FTL_1232) encodes a protein of 457 amino acids sharing
29.2% identity (and 55.3% similarity) with TrkA of E. coli and
SapG of S. typhimurium [34]. Of note, the N-terminus of FTL_1232
bears the characteristic nucleotide-binding motif GXGXXG
found in TrkA porteins (Figure 1C).
Genomic analyses suggest that F. tularensis subsp. tularensis and
holarctica possess a single potassium transporter, a Trk-like
transporter encoded by trkH and trkA. Indeed, the LVS and Schu
S4 genomes presumably encode an inactive kdpABC potassium
uptake system due to mutations in the kdpB and kdpA gene,
respectively (Figure 2). Moreover, in both subspecies, the kdpD/E
Table 1. Summary of mutants identified in screen.
Locus Genomic location Gene Gene product Cellular role
a
FTL_1708 1,640,202 trkH Potassium uptake protein Environmental Information Processing; Membrane
Transport
FTL_1708 1,640,802 trkH Potassium uptake protein Environmental Information Processing; Membrane
Transport
FTL_1966 1,892,759 trpE Anthranilate synthase component I Metabolism; Amino Acid Metabolism
FTL_0173 177,040 aroE Shikimate 5-dehydrogenase Metabolism; Amino Acid Metabolism
FTL_1860 1,791,836 purL Phosphoribosylformylglycinamidine synthase Metabolism; Nucleotide Metabolism
FTL_1861 1,792,631 purF Amidophosphoribosyltransferase Metabolism; Nucleotide Metabolism
FTL_1962 1,889,732 Hypothetical protein Unknown
FTL_0699
b 687,717 rluD Ribosomal large subunit pseudouridine synthase D Genetic Information Processing; Translation
FTL_0028
b 27,424 pyrB Aspartate carbamoyltransferase Metabolism; Amino Acid and Nucleotide
Metabolism
aaccording to the KEGG database (http://www.genome.jp/kegg-bin/show_organism?org=ftl).
binsertion found in upstream region (11 bp upstream of rluD ; 132 bp upstream of pyrB).
doi:10.1371/journal.pone.0008966.t001
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also non-functional. In LVS, both the kdpD and kdpE genes
harbors mutation; and Schu S4 possesses only an intact kdpD gene.
In addition, no ortholog of the Kup potassium uptake system (also
designated TrkD) could be identified in any of the four F. tularensis
subsps. Hence, in both the LVS and Schu S4 strains, Trk is likely
to be the unique active potassium uptake system.
Growth Properties of the trkH Mutant in CDM
We chose for all subsequent functional studies the trkH mutant
strain carrying an insertion after the 216 bp of trkH. We first
examined the impact of trkH inactivation on the ability of LVS to
survive under low potassium conditions in broth (Figure 3). For
this, LVS and trkH mutant strains were cultivated in normal
chemically defined medium (CDM+) [35] or in CDM in which
sodium phosphate had replaced potassium phosphate as the
buffering agent (CDMx) and further supplemented with various
concentrations of potassium chloride (KCl) as a source of
potassium (ranging from 0 to 100 mM). Cultures were incubated
at 37uC and growth was monitored over a 8 h-period (Figure 3A,
B). The LVS strain grew normally in CDM+ medium while no
growth was observed in CDMx devoid of potassium. The addition
of only 10 mM potassium was sufficient to restore partial growth of
LVS and normal growth was observed at and above 1 mM (ie.
identical to that in CDM+, whose potassium concentration is
approximately 18 mM). In contrast, the trkH mutant failed to grow
at potassium concentrations at and below 10 mM. Growth
comparable to wild type LVS was only restored at 100 mM
potassium. Notably, partial growth of the trkH mutant was
observed in CDM+, while on solid CDM+ medium, growth of
the mutant was totally impaired.
We confirmed that the growth defect observed on CDM with
the trkH mutant strain was due to the specific inactivation of
FTL_1708 by performing a functional complementation of the
gene. For this, the recombinant plasmid pC-trkH carrying the wild-
type trkH allele was introduced into the trkH mutant strain. On
Figure 1. Genetic organzation of the trkH region and multiple alignments of the TrkH, TrkA proteins. (A) The gene FTL_1708 (trkH)i s
flanked by two genes in opposite orientation. Parenthetic numbers give the sizes (in base pairs) of the intergenic regions flanking FTL_1708. (B)
Alignment of the TrkH proteins of F. tularensis strains LVS (designated Ftl), Schu S4 (designated ftu) and TrkH of S. typhimurium LT2 (designated Stm)
were performed using the Clustal W program. Residues that are identical in all strains (boxed in pink) are marked by ‘‘*’’, conserved substitutions by a
‘‘:’’, and semi-conserved substitutions by a ‘‘.’’ (C) Alignment of the N-terminal end of TrkA (from E. coli K12 and S. typhimurium LT2, upper line) and F.
tularensis (from Schu S4 and LVS, lower line) encompassing the characteristic nucleotide binding motif GXGXXG at the N-terminus of TrkA. Pink
residues are the conserved glycines involved in nucleotide binding.
doi:10.1371/journal.pone.0008966.g001
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PLoS ONE | www.plosone.org 3 January 2010 | Volume 5 | Issue 1 | e8966Figure 2. The kdp locus in F. tularensis subsp. holartica (LVS), novicida, and tularensis. The prototypical Kdp potassium transport system
comprises: i) the transporter, composed of KdpA, KdpB and KdpC; and ii) the TCS, regulating its expression, and composed of KdpD, the sensor
kinase; and KdpE, the response regulator. Upper line, the LVS locus. Whenever an FTL number has been attributed, it is indicated above the orf.
Middle line, F. tularensis subsp. novicida which comprises an intact kdp locus. A, B, D and E, above each gene refer to kdpA, kdpB, kdpC, kdpD and
kdpE, respectively. Lower line, F. tularensis subsp. tularensis. In dark grey, the intact genes; in light grey, the interrupted genes (but annotated as
genes in the KEGG database); in red, the interrupted genes annotated as pseudogenes (in KEGG). KdpB.I nF. tularensis subsp. novicida, the kdpB
gene (FTN_1717; 2,040 bp) encodes a 679 aas protein. In LVS, the proximal portion of the gene carries: i) an in frame 63 bp deletion (deletion of
nucleotides 509 to 571); and ii) a single nucleotide insertion (between nucleotides 1,096 and 1,097; FTN_1717 numbering), leading to a premature
termination of the coding sequence (creation of a TGA stop codon 9 bp downstream of the insertion). The resulting 374 aas truncated protein is
designated FTL_1882. An ATG codon (in frame with the rest of the kdpB sequence of FTN_1717) is found immediately downstream of the stop codon
(29 bp) of FTL_1882, leading to the prediction of a second open reading frame of 301 aas designated FTL_1881. Blastn analysis of the nucleotide
sequence of LVS corresponding to gene FTN_1717 (i.e. 1,978 bp from the start codon of FTL_1882 to the stop codon of FTL_1881) reveals that the
entire LVS sequence is 100% identical to F. tularensis subsp. holarctica FTNF002-00 genome region 1,811,308 to 1,809,331 and .99% identical to F.
tularensis subsp. holarctica OSU18 genome region 1,815,047 to 1,813,070 (with a unique C to A substitution at position 71 of FTL_1882). Thus, in the
three subsp. holarctica genomes available, the proximal part of the kdpB gene carries the same in frame deletion and the gene is interrupted by
the same single nucleotide insertion. KdpD.I nF. tularensis subsp. novicida, the kdpD gene (FTN_1715; 2,682 bp) encodes a 893 aas protein. In LVS,
the corresponding gene is interrupted by a single nucleotide insertion (between nucleotides 981 and 982; FTN_1715 numbering), leading to a
premature termination of the coding sequence (creation of a TGA stop codon 32 bp downstream of the insertion). The resulting truncated predicted
orf is designated FTL_1879 (337 aa). An ATG codon (in frame with the rest of the kdpD sequence of FTN_1715) is found downstream of the stop codon
(92 bp) of FTL_1879, leading to the prediction of a second orf of 525 aas, designated FTL_1878. Blastn analysis of the nucleotide sequence of LVS
(2,683 bp) corresponding to gene FTN_1715 reveals that the entire LVS sequence is 100% identical to F. tularensis subsp. holarctica OSU18 genome
region 1,812,395 to 1,809,713100 and 99% identical to F. tularensis subsp. holarctica FTNF002-00 genome region 1,808,656 to 1,805,974 (with 3 single
nucleotide substitutions). Thus, in the three subsp. holarctica genomes available, the kdpD gene is interrupted by the same single nucleotide
insertion. KdpE.I nF. tularensis subsp. novicida, the kdpE gene (FTN_1714; 687 bp) encodes a 228 aas protein. In LVS, the corresponding region is not
predicted to encode a protein (FTL_1877 is designated pseudogene). Comparison of the F. tularensis subsp. novicida and LVS nucleotide sequences
reveal the presence of a 13 bp deletion in the proximal portion of the LVS sequence (deletion of nucleotides 45 to 57, FTN_1714 numbering),
resulting in a frame shift and the premature termination of the protein sequence (a TGA stop codon is found 11 bp downstream of the deletion).
Blastn analysis of the nucleotide sequence of LVS (671 bp) shows a 100% identity with the F. tularensis subsp. holarctica OSU18 genome region
1,809,671 to 1,809,001; and .99% identity with F. tularensis subsp. holarctica FTNF002-00 genome region 1,805,932 to 1,805,262 (1 single nucleotide
substitution) as well as with F. tularensis subsp. tularensis Schu S4 genome region 1,823,954 to 1,823, 284 (2 single nucleotide substitution). Thus, in
the three subsp. holarctica genomes available and in Schu S4, the kdpE gene is a pseudogene resulting from the same 13 bp deletion. The regions
containing the mutations in genes kdpB (FTL_1881-1882), kdpD (FTL_1878-1879) and kdpE (FTL_1877), have been resequenced by sequencing of
cloned PCR products. This analysis fully confirmed the published sequence of LVS.
doi:10.1371/journal.pone.0008966.g002
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was indistinguishable from that of wild-type LVS. In CDM+
plates, growth of the trkH mutant was severely reduced and
introduction of the recombinant plasmid pC-trkH restored normal
growth (Figure 4). The apparent morphological differences
between the growth of the WT and the complemented strains
on CDM most likely reflects the faster growth of LVS on CDM
solid medium.
These data confirm the absolute potassium requirement for
LVS growth. Furthermore, supporting the in silico analyses, the
properties of the trkH mutant strongly suggest that TrkH is the
major potassium transporter of LVS.
Sensitivity to Serum and to Osmotic Shock
The Trk system of V. vulnificus has been reported to be required
for serum resistance [33]. This prompted us to examine the impact
of trkH inactivation on sensitivity to non-decomplemented human
serum. The serum had no effect on the viability of the trkH mutant
and the wild-type strain at all tested concentrations (0–20%)
(Figure 5A). Hence, in F. tularensis LVS, the Trk system is not
involved in serum-resistance.
Bacteria respond to variations in the external osmolarity by
accumulating or releasing low molecular weight solutes [36]. The
most rapid response to osmotic upshift is potassium uptake via
specialized transport systems (that in turn triggers other osmotic
responses)[37,38] and the Trk system has been shown to play an
important role in this process [36]. A recent study revealed that in
the gram-negative symbiotic bacterium Sinorhizobium melitoti, the
Trk system was the main system involved in accumulation of
potassium after an osmotic shock [39]. We therefore monitored
(Figure 5B) the impact of trkH inactivation on the ability of LVS
to survive under high osmotic conditions. LVS and trkH mutant
strains were cultivated in Schaedler K3 medium supplemented
with either 0 mM, 200 mM or 400 mM NaCl and cultures were
incubated at 37uC. Growth of LVS was not affected in the
presence of 400 mM NaCl. For unknown reasons, LVS grew even
to higher OD600 in the presence of 200 mM NaCl than in normal
Schaedler K3 medium. In contrast, growth of the trkH mutant was
significantly reduced in the presence of 200 mM NaCl and growth
was essentially abolished in the presence of 400 mM NaCl. These
Figure 3. Growth properties of the trkH mutant in chemically definded medium. LVS (A) and trkH (B) were grown in chemically defined
medium (CDM+) or in CDMx buffered with sodium phosphate and supplemented with KCl as potassium source (at concentrations indicated in
legend).
doi:10.1371/journal.pone.0008966.g003
Figure 4. Functional complementation. Bacteria were grown in
Schaedler K3 until an OD600 of 0.3. Ten ml of each culture (nd: non
diluted, corresponding to ca.1 0
7 b) and of serial ten-fold dilutions, were
spotted onto: CDM agar plate (A) and Chocolate agar plate (B). LVS:
wild-type strain; TrkH: the trkH mutant derivative; TrkH/pC: the trkH
mutant transformed with plasmid pC-trkH (a pFNLTP6 derivative
carrying a wild-type trkH allele under control of the gro promoter).
doi:10.1371/journal.pone.0008966.g004
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shock.
Impact of the trkH Mutation on Bacterial Virulence
To examine if TrkH contributes to Francisella pathogenesis, we
first compared the ability of F. tularensis LVS and the trkH mutant
to multiply inside macrophages in vitro. For this, we infected
murine macrophage-like J774 cells, mouse bone marrow-derived
macrophages, and human macrophage THP1 cells with the wild
type and mutant strains. In all cell types, intracellular growth of
the trkH mutant was undistinguishable from that of the wild-type
strain (Figure 6), indicating that trkH inactivation has no impact
on intracellular survival of LVS.
Then, to determine if TrkH is important for the ability of F.
tularensis to cause disease, we infected 6–8 weeks old BALB/c mice
with the LVS and trkH strains. Groups of five mice were
inoculated by the intraperitoneal (i.p.) route with different
numbers of bacteria and survival of the mice was followed for
10 days (Figure 7). None of the mice infected with LVS at doses
of 100 bacteria survived infection. In contrast, all mice survived
infection with trkH with doses up to ,10
5 bacteria and only
infection with a dose of ,10
6 trkH bacteria or higher resulted in
death. These results demonstrate that virulence is severely
attenuated in the trkH mutant.
To investigate the fate of the bacteria inside host tissues, we
infected mice with ,10
4 LVS or trkH bacteria and followed the
kinetics of infection by assessing the number of viable bacteria in
the spleen, liver and whole blood. Groups of five mice were
sacrificed 2, 3, 4, and 7 days after infection and viable bacterial
numbers were determined by plating of diluted tissue homogenates
(Figure 8A, B). Blood samples, collected before the mice were
sacrificed, were also plated for numerations. LVS increased in
numbers from day 2 to day 4 post-infection, reaching $10
8
bacteria per organ (spleen and liver, Figure 8A, B) and none of
the mice infected with LVS survived the infection to day 7. The
trkH strain was initially detected in both spleen and liver at
identical or slightly lower levels than the wild-type strain. The
bacterial numbers then remained high and constant up to day 4 in
both organs (10
6–10
7 per organ). On day 7, bacterial numbers had
significantly decreased but both spleen and liver were still infected
(Figure 8A, B) and all mice survived the infection. These data
indicate that the trkH mutant is able to infect mice and to persist
for some days in the infected organs. However, it is unable to
multiply efficiently inside host tissues and cause disease.
In whole blood, the number of bacteria recorded at day 2 was
slightly higher for LVS than for the trkH mutant (Figure 8C).
Strikingly, at day 3, the number of LVS bacteria in blood was
increased whereas the number of trkH mutant bacteria had
drastically diminished. The number of mutant bacteria was even
lower the following day (when wild type bacteria had reached a
plateau) and trkH bacteria were almost absent in the blood at day 7
(Figure 8C).
Hence, at days 3 and 4 when only approximately a ten-fold
difference in bacterial numbers was observed in the organs of mice
infected with either LVS or the trkH mutant, a 1,000-fold
difference was recorded in the blood.
Ex Vivo Multiplication in Murine Blood
To further examine the apparent decreased capacity of the trkH
mutant to survive in host blood, we incubated LVS and trkH
mutant bacteria in murine blood ex vivo. Heparinized blood
collected from 8 mice was inoculated with LVS or trkH and the
viable number of bacteria was determined after 24 and 48 h of
incubation at 37uC. As had been observed previously [26], LVS
multiplied and increased in numbers after incubation in murine
blood (Figure 9). In contrast, the viable number of the trkH
mutant was diminished considerably over the 48 h period, strongly
indicating that the mutant fail to multiply in murine blood as the
wild type parent strain.
Discussion
The present work identifies for the first time a gene involved in
the extracellular phase of F. tularensis infectious cycle and unravels
a novel –mineral- nutritional requirement of F. tularensis. Our
Figure 5. Resistance to serum and high osmolarity. Survival of LVS (closed symbols) and trkH mutant (open symbols) after 1 hour incubation in
human non-decomplemented serum (0–20%) (A). Growth of LVS (closed symbols) and trkH (open symbols) in CDM supplemented with NaCl as
indicated in legend (B).
doi:10.1371/journal.pone.0008966.g005
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in F. tularensis pathogenesis, by screening banks of F. tularensis LVS
mutants on chemically defined medium. The unexpected selection
of a transposon insertion mutant in a gene encoding a homolog of
the potassium permease TrkH, prompted us to address the role of
this mineral in F. tularensis pathogenesis. We found that the trkH
mutant required a high level of potassium supplementation to
grow in broth. This mutant multiplied normally in cells in culture,
but was particularly affected in its ability to survive and multiply in
the blood of infected animals.
Trk Constitutes the Unique Functional Potassium Uptake
System of F. tularensis
A relatively constant and high intracellular potassium concen-
tration (300 to 500 mM) appears to be essential for bacteria,
notably, to maintain cell turgor and to adapt to osmotic variations
[36]. For this, bacteria often possess multiple dedicated active
potassium transport systems (ion pumps and exchangers) and three
major types of transporters have been identified. Trk and Kup are
two low affinity potassium transport systems, which are constitu-
tively expressed. The third system is a high affinity system, Kdp,
which is normally induced at low potassium concentration. The
Trk transporters are widespread in bacteria and in media
containing more than 1 mM potassium, Trk is the predominant
uptake system. Kup is a potassium uptake system of modest affinity
that is found in some bacteria. Kup activity in E. coli is more
important at low pH where its maximum rate exceeds that of Trk.
Finally, Kdp is an inducible P-type ATPase expressed only when
the needs for potassium are not satisfied by other transport
systems, and thus plays a vital role when the ion is present at
concentrations too low to be efficiently taken up by the other
potassium transport systems. Transcription of the inducible kdp
operon is tightly regulated by a two-component system (TCS),
composed of the sensor kinase KdpD and the response regulator
KdpE [40].
Most of the studies on the role of potassium uptake in bacteria
have been carried out in non-pathogenic species. The only two
examples describing a role for potassium uptake systems in
bacterial pathogenesis concern the intracellular pathogen S.
Figure 6. Intracellular replication of LVS and trkH strains.
Intracellular bacterial replication was monitored over a 48 h-period in
J774 macrophage like cells (A), in THP1 human macrophages (B), and in
mouse bone marrow-derived macrophages (BMM) from BALB/c mice
(C). Results are shown as the average of log10 (CFU well
21) 6 standard
deviation. Closed symbols designate the LVS strain and open symbols
the trkH strain.
doi:10.1371/journal.pone.0008966.g006
Figure 7. The trkH mutant is attenuated for virulence in mice.
Groups of five BALB/c mice were infected with LVS (closed symbols) or
trkH (open symbols) bacteria at different doses by the i.p. route. The
log10 of the numbers of bacteria used for infection are shown in legend
in parenthesis. The survival of mice (in %) was followed for 10 days after
infection.
doi:10.1371/journal.pone.0008966.g007
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[42]. S. typhimurium seems to possess all three known potassium
uptake systems (TrK, Kdp and Kup). In contrast, H. pylori lacks all
three systems and is likely to take up potassium only via potassium
channels. Of note, a recent screen in Vibrio cholerae for in vivo
inducible genes in humans identified 217 candidate genes,
including the trkH and trkA genes [43]. However, the contribution
of trkH and trkA to bacterial virulence was not addressed. Our
genomic analyses suggest that F. tularensis subsp. tularensis and
holarctica possess only a Trk-like potassium transporter. The fact
that the trkH mutant was selected on the basis of impaired growth
on solid CDM (which contains ca. 18 mM potassium) further
supports this notion. The ability of the trkH mutant of LVS to grow
at high external potassium concentration suggests that enough
potassium can cross the bacterial envelope, possibly via hypothet-
ical diffusion channels, to promote survival.
Importance of Potassium for In Vivo Dissemination of F.
tularensis
Bacteraemia is a severe complication of a number of infections
and can have several dramatic consequences such as sepsis and
septic shock, particularly with gram-negative bacteria [44]. A
number of pathogenic bacterial species use blood to spread from
their initial port of entry through the infected host, and establish
infectious foci in specific target organs or tissues [45]. These
bacteria have therefore developed a number of defense mecha-
nisms to survive killing in this hostile environment. In addition to
defense mechanisms, such as resistance to complement-mediated
lysis or resistance to antimicrobial peptides, survival and
multiplication in blood requires bacterial adaptation to this
peculiar nutritional environment. However, only limited informa-
tion is currently available on the nature of bacterial requirements
in blood. For example, iron is known to be an essential ion for the
majority of bacterial species. The selection and analysis of
auxotrophic mutants have also highlighted the role of amino acid
and nucleic acid uptake and biosynthesis in the virulence of a
number of pathogenic bacteria. However, the specific requirement
of these systems for blood stage dissemination is not established.
Interestingly, a recent study [30] has demonstrated that de novo
synthesis of purines and pyrimidines was required for survival of E.
coli in human blood. Furthermore, inactivation of nucleotide
biosynthesis genes in Bacillus anthracis and S. typhimurium also
prevented growth in human serum, strongly suggesting that
nucleotide precursors are limiting for bacterial growth in blood.
Remarkably, while the potassium concentration is higher than
100 mM inside human cells, the extracellular concentration in
mammalian hosts are usually less than 10 mM [46], and the
normal concentration of potassium in human blood serum is only
3.5 to 5.0 mM [47]. Hence, it is reasonable to assume that
adaptation to variations in potassium concentration must play an
important role in the pathogenicity of facultative intracellular
pathogens, such as F. tularensis, which are also found free in the
bloodstream during systemic dissemination. Although the role of
potassium homeostasy in the physiology of eukaryotic organisms
has been extensively studied [48], the role of potassium acquisition
systems in the virulence of human pathogens has not been well
characterized [41,42,49].
We used here a simple screen on chemically defined medium
(CDM) to search for potentially new nutritional requirements of F.
Figure 8. In vivo dissemination of LVS and trkH. BALB/c mice were infected with approximately 10
4 LVS or trkH bacteria by the i.p. route. After
2, 3, 4, and 7 days of infection, groups of five mice were sacrificed and the bacterial burden in the spleen, liver, and blood was determined by plating
tissue homogenates on chocolate agar. *: all mice infected by LVS died before day 7.
doi:10.1371/journal.pone.0008966.g008
Figure 9. Multiplication of trkH mutant is impaired in murine
blood ex vivo. Heparinized blood samples from eight mice were
inoculated with ,5610
4 bacteria ml
21 and incubated at 37uC with
shaking for 24 and 48 h, at which point the number of viable bacteria
was determined. Closed symbols correspond to the LVS strain and open
symbols the trkH mutant.
doi:10.1371/journal.pone.0008966.g009
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encoding the predicted potassium permease TrkH of the Trk
uptake system. Remarkably, the trkH gene had never been
identified in previous screens. While the mutant grew only poorly
in CDM (containing 18 mM potassium), normal growth of the
trkH mutant was restored by adding potassium at high concentra-
tion, establishing the importance of TrkH in potassium acquisi-
tion. Furthermore, as would be expected of a mutant in the
potassium transporter, growth of the trkH mutant was also
significantly reduced at high osmolarity. In contrast, inactivation
of trkH had only marginal impact on the capacity of the bacterium
to multiply intracellularly in mouse or human cell lines and in
primary bone marrow macrophages. This result is not surprising
given the high potassium content (100–300 mM range) of
eukaryotic cells. However, the virulence of the trkH mutant was
markedly attenuated. In vivo kinetics of bacterial multiplication
revealed a rapid elimination of the trkH mutant, particularly in the
blood of infected mice. The specific growth defect of the trkH
mutant was further confirmed in blood ex vivo. LVS multiplied
after incubation in murine whole blood [26] while the trkH mutant
failed to multiply.
At any rate, it cannot be excluded that the impaired survival in
CDM and virulence defect of the trkH mutant might not be totally
attributable to its potassium uptake deficiency. It could be due, for
example, to another unreported function of the protein or to
another spontaneous mutation or to some polar effects.
It has been previously shown that in bacteremic mice, bacteria
were mainly extracellular and that moreover, both F. tularensis
LVS and Schu S4 failed to grow in murine plasma [26]. We also
found that LVS (and the trkH mutant) was not able to multiply in
mouse serum (not shown), suggesting that they require host cells or
cellular component to replicate in blood. We are currently
evaluating the transcriptomic response of F. tularensis LVS in
mouse serum to further understand how the bacterium adapts to
this peculiar nutritional environment.
In conclusion, the potassium requirement specific to the blood
stage is in support of the importance of the extracellular phase in
F. tularensis pathogenesis. More generally, active potassium uptake
systems are likely to be important for all bacterial pathogens able
to disseminate in vivo extracellularly via the hematogenous route.
Specific inhibition of TrkH could lead to the development of
potential new therapeutic strategy against F. tularensis, which might
be applicable to other bacteria with systemic dissemination.
Materials and Methods
Strains, Media and Chemicals
F. tularensis LVS strain was obtained from Dr Anders Sjo ¨stedt
(Umea ˚ University, Sweden), and grown at 37uC in Schaedler K3
broth (Biomerieux SA Marcy l’Etoile, France), Chamberlain
defined synthetic medium [35] or chocolate agar enriched with
PolyViteX (chocolate agar) (Biomerieux). E. coli was grown in
Luria-Bertani (LB) medium at 37uC. When required, the medium
was supplemented with kanamycin (10 mgm l
21). Kanamycin was
purchased from Sigma-Aldrich (St Louis, MO). Oligonucleotide
primers were synthesized by Eurogentec (France). Primers and
bacterial strains used in this study are listed in Table 2.
Generation of Banks of LVS Mutants and Screening
Procedure
We used the modified pHimar3 suicide mutagenesis system
[22], derived from the temperature sensitive plasmid pFNLTP16
H3, to generate F. tularensis mutant libraries [31]. As described
previously, the pFNLTP16 part of the plasmid was removed by
digestion with NotI followed by ligation. The resulting 4.3 kb
pHimar3 plasmid (containing the HimarFT transposon, the
Table 2. Bacterial strains, plasmids, and oligonucleotides used in study.
Strain, plasmid, or primer Description Reference
E. coli
DH5al pir F2 w80lacZDM15 endA1 recA1 hsdR17 supE44 thi-1 gyrA96 relA1 D(lacZYA-argF)U169,
lysogenized with lpir phage; used a host for HimarFT rescue
Laboratory strain collection
F. tularensis
LVS F. tularensis subspecies holarctica live vaccine strain Laboratory strain collection
LVS trkH::HimarFT LVS containing a HimarFT insertion in trkH This study
Plasmids
pFNLTP16 H3 E. coli-F. tularensis temperature sensitive shuttle vector containing HimarFT,K m
r Ap
r [31]
pHimar 3 4.3 kb derivative of pFNLTP16 H3 lacking F. tularensis replicon (repA),K m
r This study and [22]
pFNLTP6gro Shuttle vector with F. tularensis groEL promoter, Km
r Ap
r [31]
p6Tc-gro Derivative of pFNLTP6gro, Tc
r This study
p6Tc-gro-trkH p6Tc-gro with fragment harboring trkH and upstream and downstream regions cloned




K1 59-GCTATTCGGCTATGACTG-39, forward primer for kanamycin marker (npt) probe [31]
K2 59-CAGCAATATCACGGGTAG-39, reverse primer for kanamycin marker (npt) probe [31]
K3 59-GCTTCCTCGTGCTTTACGG-39, npt primer for HimarFT insertion sequencing [31]
R1 59-TGCCACCTAAATTGTAAGCG-39, R6K primer for HimarFT insertion sequencing [31]
E1 59-CCGGAATTCGGAAACTAGCTTTAGGCTTTG-39, forward primer for complementation
E3 59-CCGGAATTCCGATTACAAAGTTATCGCATATG-39, reverse primer for complementation
doi:10.1371/journal.pone.0008966.t002
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the control of Francisella groEL promoter and the E. coli-compatible
origin of replication oriR6K) was transformed into E.coli DH5al pir,
and selection of transformants was performed on LB agar
containing 50 mgm l
21 of kanamycin. Transposition of the
HimarFT transposon was performed by electroporation of 100–
200 ng of plasmid pHimar3 into electrocompetent LVS. Electro-
poration was performed as described previously [24]. Trans-
formed cells were grown in Schaedler K3 for 3 h at 37uC with
shaking and then spread onto chocolate agar plates enriched with
BD BBL
TMIsoVitaleX (Becton Dickson) and containing 10 mg
ml
21 of kanamycin. Plates were incubated at 37uC for 3–4 days to
recover individual clones containing single HimarFT chromosomal
insertion.
To isolate auxotrophic Francisella LVS mutants, we screened a
library of 2,500 mutants for growth on CDM agar plates. For this,
individual colonies were simultaneously streaked onto chocolate
agar and CDM plates. A series of mutants which were unable to
grow on CDM after 24 h of incubation at 37uC were selected and
further analyzed by Southern blot as described previously [24].
Southern blot analysis performed on the two trkH mutants and on
the 4 auxotroph mutants, confirmed that they (Table 2) contained
a single chromosomal transposon insertion (Figure S1).
Determination of the Insertion Site
Transposon insertion sites were mapped as described previously
[24]. Briefly, genomic DNA was isolated from each mutant strain
and 1 mg was digested with SpeI overnight and subsequently ligated
with T4 DNA ligase. Himar-containing fragments were recovered
as plasmids in E. coli DH5al pir and the transposon insertion site
was determined by sequencing. The genomic location of each
transposon insertion is listed in Table 1.
Cell Cultures and Macrophage Infection
J774 (ATCC Number: TIB67) and THP1 (ATCC Number:
TIB-202
TM) cells were propagated in RPMI or Dulbecco’s
Modified Eagle’s Medium (DMEM) containing 10% fetal calf
serum. Cells were seeded at a concentration of ,2610
5 cells per
well in 12-well cell tissue plates and monolayers were used 24 h
after seeding. Bone marrow-derived macrophages (BMM) from
BALB/c mice were obtained and cultured as described [24]. J774
and THP1 macrophage monolayers were incubated for 90 min
and BMM for 60 min at 37uC with the bacterial suspensions
(approximate multiplicities of infection 100) to allow the bacteria
to enter. After washing (time zero of the kinetic analysis), the cells
were incubated in fresh culture medium containing gentamicin
(10 mgm l
21) to kill extracellular bacteria. At several time-points,
cells were washed three times in RPMI or PBS, macophages were
lysed by addition of water and the titer of viable bacteria released
from the cells was determined by spreading preparations on agar
plates. For each strain and time in an experiment, the assay was
performed in triplicate. Each experiment was independently
repeated at least two times and the data presented corresponds
to one typical experiment.
Infection of Mice and Virulence Assays
Animal experiments were approved by the Institut National de
la Sante ´ et de la Recherche Me ´dicale (INSERM) and performed
according to the guidelines of the INSERM for laboratory animal
husbandry.
Bacteria were grown in Schaedler K3 medium to an OD600 of
0.3–0.4 and then diluted to the appropriate concentration (CFU/
ml) in 0.15M NaCl. 6- to 8-week-old female BALB/c mice (Janvier,
Le Genest St Isle, France) were i.p. inoculated with 200 mlo f
bacterial suspension. Groups of five mice were inoculated with
various doses of bacteria and the mortality was followed for 10 days.
The actual number of viable bacteria was determined by plating
dilutions of the bacterial suspension on chocolate agar.
For experiments following the kinetics of infection, BALB/c mice
wereinfected with ,10
4 CFU of LVSor trkH mutant bacteria.At 2,
3, 4, and 7 days after infection, groups of five mice were sacrificed
and the bacterial number was determined in the liver, spleen and
blood by plating homogenized samples on chocolate agar plates.
Functional Complementation
First, the plasmid p6Tc-gro was constructed by substituting a
PvuI-PstI fragment of pFNLTP6gro with the tet gene amplified by
PCR from plasmid pACYC184. Then, the trkH gene and
upstream region was amplified by PCR using primers E1 and
E3 and cloned in the EcoRI site of p6Tc-gro, yielding recombinant
plasmid pC-trkH. The sequence of trkH was verified by
sequencing. The recombinant plasmid pC-trkH was introduced
in the trkH mutant strain by electroporation.
Sensitivity to Human Serum
The sensitivity assay was performed essentially as described
previously [50]. Briefly, bacteria (5610
5) from mid-exponential
phase cultureweresuspended in0.5 mlof RPMIcontaining 20 mM
HEPES (N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic acid)
buffer (PAA laboratories GmbH). The suspensions were incubated
at 37uC with shaking in the presence of increasing concentration of
non-decomplemented human serum (0–20%) (PAA Laboratories,
GmbH Pasching). Serial dilutions in RPMI-HEPES were plated on
chocolate agar plates to determine the number of viable bacteria at
the beginning and after 1 h of incubation.
Kinetics of Growth and Stress Resistance
We studied the growth kinetics of the two strains in CDMx
containing increasing concentrations of potassium in the form of
KCl (0, 10 mM, 100 mM, 1 mM, 10 mM and 100 mM). The
KH2PO4 and K2HPO4 present in normal CDM were substituted
by NaH2PO4 and Na2HPO4 to maintain the proper pH.
To test sensitivityto osmotic shock, LVSand thetrkHstrains were
grown in the absence or in the presence of high concentration of
NaCl. Bacteria were grown overnight in Schaedler K3 medium and
then diluted 10-fold in fresh medium containing either 200 mM or
400 mM NaCl and incubated at 37uC with agitation. Growth was
assessed by measuring the optical density at 600 nm.
Growth of LVS and TrkH Mutant in Murine Blood
Animal experiments were performed according to the guidelines
of the Institut National de la Sante ´ et de la Recherche Me ´dicale
(INSERM) for laboratory animal husbandry.
Terminal blood was collected from eight 6– to 8-week-old
female BALB/c mice (Janvier, Le Genest St Isle, France) using
heparin as an anticoagulant (200 UI of heparin ml
21). Each blood
sample was divided in 4 fractions in sterile 2 ml tubes. Two
fractions of each sample were inoculated with ,5610
4 bacteria
(10 ml in 0.15M NaCl solution) of either LVS or trkH mutant.
Fractions were incubated at 37uC with agitation (120 rpm). The
number of viable bacteria was determined at 24 h and 48 h by
plating serial dilutions on chocolate agar.
Bioinformatics Analyses
LVS genome sequence analyses were performed essentially
from the KEGG database (http://www.genome.jp/kegg-bin/
show_organism?org=ftl) and associated sofware.
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entrez Genome project site (http://www.ncbi.nlm.nih.gov/sites/
entrez?db=genomeprj&cmd=Retrieve&list_uids=20197,16421,
17265,19571,17375,9,18459).
The program BLASTN 2.2.22 was used on the nucleotide




Protein sequence similarity searches were performed using
BLASTP [51] against non-redundant protein data bases. Multiple
sequence alignment of homologous sequences was carried out
using ClustalW [52].TMHMM server version 2.0 (http://www.
cbs.dtu.dk/services/TMHMM-2.0/) was used to perform TMS
predictions.’’
Supporting Information
Figure S1 Southern blot analysis. Genomic DNA (5 mg) of six
transposon insertion mutants was digested with SpeI overnight,
resolved on a 0.7% agarose gel and transferred to a positively
charged nylon membrane (Amersham Pharmacia, RPN203B) by
capillary action for 4 h. Blots were probed with DNA fragments
randomly labeled using random prime labelling system kit
(Rediprime
TM II, Amersham pharmacia, RPN16330l/AE), for
which a 634-bp fragment corresponding to the neomycin
phosphotransferase (npt) gene was used as probe. pHimar3.4,
SmaI-linearized plasmid pFNLTP16 H3; trkH-clone 1, transposon
insertion at nucleotide 216 of trkH coding sequence; trkH-clone 2,
transposon insertion at nucleotide 816 of trkH coding sequence;
trpE, transposon insertion in gene FTL_1966 ; aroE, transposon
insertion in gene FTL_0173; purL, transposon insertion in gene
FTL_1860 ; purF, transposon insertion in gene FTL_1861.
Found at: doi:10.1371/journal.pone.0008966.s001 (1.26 MB TIF)
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